ACTU Actuate Therapeutics, Inc. - Common stock
ACTU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
ACTU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
ACTU Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 2 20.0%
- Buy 7 70.0%
- Hold 1 10.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
4 analysts · 2026-08-16Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.24 | $-0.22 | -0.02% |
| Dec. 31, 2025 | $-0.18 | $-0.25 | 0.07% |
| Sept. 30, 2025 | $-0.25 | $-0.28 | 0.03% |
| June 30, 2025 | $-0.31 | $-0.32 | 0.01% |
| March 31, 2025 | $-0.32 | $-0.31 | -0.01% |
| Dec. 31, 2024 | $-0.33 | $-0.30 | -0.03% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ACTU | $142M | -5.8 | — | — | -843.5% | — |
| ATOS | $5M | -0.1 | — | — | -71.7% | — |
| ABVC | $53M | -5.5 | 234.3% | — | -128.2% | — |
| LGVN | — | -0.4 | -49.9% | -1893.6% | -247.7% | 67.0% |
| JSPR | — | -0.5 | — | — | — | — |
| ALLR | $17M | -0.0 | — | -3509.7% | -102.1% | — |
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $10M | $19M | $22M | |
| SG&A Expense | $12M | $6M | $3M | |
| Operating Expenses | $22M | $25M | $25M | |
| Operating Income | $-22M | $-25M | $-25M | |
| Interest Income | $287.7K | $222.3K | $352.7K | |
| Other Non-op | $267.5K | $-2M | $229.2K | |
| Income Tax | $800 | $800 | $0 | |
| Net Income | $-22M | $-27M | $-25M | |
| EPS (Basic) | $-1.06 | $-3.26 | $-17.24 | |
| EPS (Diluted) | $-1.06 | $-3.26 | $-17.24 | |
| Shares (Basic) | 21,021,817 | 8,372,741 | 1,434,964 | |
| Shares (Diluted) | 21,021,817 | 8,372,741 | 1,434,964 | |
| EBITDA | $-22M | $-25M | · |
Balance Sheet 14
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $13M | $9M | · | |
| Prepaid Expense | $484.0K | $566.3K | $36.9K | |
| Current Assets | $14M | $9M | $3M | |
| Other Non-current Assets | $392.5K | $110.5K | $0 | |
| Total Assets | $14M | $9M | $3M | |
| Accounts Payable | $2M | $2M | $3M | |
| Current Liabilities | $6M | $9M | $7M | |
| Total Liabilities | $6M | $9M | $8M | |
| Common Stock | $23 | $20 | $2 | |
| Paid-in Capital | $163M | $132M | $5M | |
| Retained Earnings | $-155M | $-132M | $-105M | |
| Stockholders' Equity | $8M | $104.2K | $-100M | |
| Liabilities + Equity | $14M | $9M | $3M | |
| Shares Outstanding | 23,245,203 | 19,531,636 | 1,690,760 |
Cash Flow 7
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $6M | $2M | $423.5K | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-19M | $-22M | $-22M | |
| Stock Issued | $4M | $0 | · | |
| Net Stock Activity | $4M | · | · | |
| Financing Cash Flow | $24M | $28M | $4M | |
| Taxes Paid | $800 | $800 | $0 |
Profitability 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -190.3% | -443.2% | · | |
| ROE | -843.5% | -998.9% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 2.4 | 1.0 | · | |
| Quick Ratio | 2.3 | 1.0 | · |
Valuation (TTM) 7
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-22M | $-27M | · | |
| Market Cap | $142M | $155M | · | |
| P/E | -5.8 | -2.4 | · | |
| P/B | 18.0 | 1492.3 | · | |
| P / Tangible Book | 18.0 | 1492.3 | · | |
| P / Cash Flow | -7.4 | -7.1 | · | |
| Earnings Yield | -17.3% | -40.9% | · |
Income Statement 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $7M | $7M | |
| SG&A Expense | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $1M | $912.8K | $969.4K | |
| Operating Expenses | $5M | $6M | $5M | $5M | $6M | $6M | $7M | $5M | $5M | $8M | $8M | |
| Operating Income | $-5M | $-6M | $-5M | $-5M | $-6M | $-6M | $-7M | $-5M | $-5M | $-8M | $-8M | |
| Interest Income | $45.0K | $85.3K | $139.6K | $70.0K | $24.5K | $53.6K | $118.1K | $80.7K | $8.6K | $14.8K | $59.7K | |
| Other Non-op | $40.0K | $80.2K | $134.5K | $64.9K | $19.5K | $48.6K | $113.0K | $-578.1K | $-1M | $-522.8K | $3.0K | |
| Net Income | $-5M | $-6M | $-5M | $-5M | $-6M | $-6M | $-6M | $-6M | $-7M | $-8M | $-8M | |
| EPS (Basic) | $-0.20 | $-0.24 | $-0.19 | $-0.25 | $-0.30 | $-0.32 | $6.89 | $-0.55 | $-4.20 | $-5.40 | $-5.11 | |
| EPS (Diluted) | $-0.20 | $-0.24 | $-0.19 | $-0.25 | $-0.30 | $-0.32 | $6.89 | $-0.55 | $-4.20 | $-5.40 | $-5.11 | |
| Shares (Basic) | 23,871,850 | 23,537,134 | -39,517,354 | 21,394,965 | 19,646,475 | 19,497,731 | -5,500,843 | 10,772,640 | 1,565,777 | 1,535,167 | 22,813 | |
| Shares (Diluted) | 23,871,850 | 23,537,134 | -39,517,354 | 21,394,965 | 19,646,475 | 19,497,731 | -5,500,843 | 10,772,640 | 1,565,777 | 1,535,167 | 22,813 | |
| EBITDA | $-5M | $-6M | · | $-5M | $-6M | $-6M | · | $-5M | $-5M | · | · |
Balance Sheet 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $8M | $13M | $17M | $6M | $4M | · | $14M | $351.7K | · | · | |
| Prepaid Expense | $322.1K | $385.4K | $484.0K | $519.2K | $195.9K | $359.2K | $566.3K | $739.3K | $198.0K | · | $36.9K | |
| Current Assets | $5M | $9M | $14M | $17M | $7M | $4M | $9M | $14M | $549.7K | · | $3M | |
| Other Non-current Assets | $451.4K | $391.8K | $392.5K | $269.9K | $280.3K | $234.5K | $110.5K | · | · | · | $0 | |
| Total Assets | $5M | $9M | $14M | $18M | $7M | $4M | $9M | $14M | $2M | · | $3M | |
| Accounts Payable | $1M | $1M | $2M | $1M | $3M | $3M | $2M | $2M | $6M | · | $3M | |
| Current Liabilities | $4M | $5M | $6M | $6M | $9M | $9M | $9M | $8M | $20M | · | $7M | |
| Total Liabilities | $4M | $5M | $6M | $7M | $10M | $10M | $9M | $9M | $22M | · | $8M | |
| Common Stock | $24 | $24 | $23 | $23 | $20 | $20 | $20 | $20 | $2 | · | $2 | |
| Paid-in Capital | $166M | $164M | $163M | $161M | $142M | $134M | $132M | $131M | $6M | · | $5M | |
| Retained Earnings | $-165M | $-160M | $-155M | $-150M | $-145M | $-139M | $-132M | $-126M | $-120M | · | $-105M | |
| Stockholders' Equity | $989.2K | $4M | $8M | $11M | $-3M | $-5M | $104.2K | $5M | $-114M | · | $-100M | |
| Liabilities + Equity | $5M | $9M | $14M | $18M | $7M | $4M | $9M | $14M | $2M | · | $3M | |
| Shares Outstanding | 24,013,577 | 23,711,677 | 23,245,203 | 23,243,328 | 20,470,504 | 19,531,636 | 19,531,636 | 19,531,636 | 1,690,760 | · | 1,690,760 |
Cash Flow 6
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $566.0K | $90.0K | $148.2K | $122.0K | |
| Operating Cash Flow | $-4M | $-5M | $-4M | $-7M | $-4M | $-5M | $-5M | $-9M | $-3M | $-5M | $-6M | |
| Stock Issued | $731.6K | $519.6K | $0 | $2M | $2M | $0 | $0 | $0 | · | · | · | |
| Net Stock Activity | · | $519.6K | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $697.0K | $-8.1K | $-29.3K | $17M | $7M | $-133.5K | $-109.4K | $22M | $957.0K | $4M | $0 | |
| Taxes Paid | $0 | $800 | $0 | $0 | $0 | $800 | $0 | $800 | $0 | $0 | $0 |
Profitability 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -80.0% | -84.0% | · | -33.8% | -136.8% | -281.8% | · | -83.7% | -759.4% | · | · | |
| ROE | 584.7% | 863.3% | · | -66.4% | 10.2% | 248.3% | · | -222.8% | 11.5% | · | · |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.8 | · | 2.7 | 0.7 | 0.5 | · | 1.7 | 0.0 | · | · | |
| Quick Ratio | 1.2 | 1.7 | · | 2.7 | 0.7 | 0.4 | · | 1.6 | 0.0 | · | · |
Valuation (TTM) 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-22M | $-23M | · | $-24M | $-25M | $-27M | · | $-27M | $-27M | · | · | |
| Market Cap | $37M | $65M | · | $155M | $125M | $132M | · | $146M | · | · | · | |
| P/E | -1.5 | -2.5 | · | -4.7 | -1.1 | -0.6 | · | -0.5 | · | · | · | |
| P/B | 37.1 | 17.2 | · | 14.2 | -47.1 | -26.0 | · | 27.2 | · | · | · | |
| P / Tangible Book | 37.1 | 17.2 | · | 14.2 | · | · | · | 27.2 | · | · | · | |
| P / Cash Flow | · | -12.9 | · | · | · | -28.6 | · | · | · | · | · | |
| Earnings Yield | -64.7% | -40.5% | · | -21.2% | -87.9% | -154.7% | · | -194.1% | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Net Income | $-22M | $-27M | $-25M |
| Diluted EPS | $-1.06 | $-3.26 | $-17.24 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Current Ratio | 2.4 | 1.0 | — |
| Quick Ratio | 2.3 | 1.0 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 66 filers · $9.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 20 (+2 vs prior Q) | 13 (+9 vs prior Q) | 18 (0 vs prior Q) | 18 (+10 vs prior Q) | +333K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2,823,872 | 461,417 | 29.24% | Shares |
| Voss Capital, LP | $2,639,250 | 1,725,000 | 27.33% | Shares |
| BIOS Capital Management, LP | $2,227,458 | 1,455,855 | 23.06% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $601,952 | 393,433 | 6.23% | Shares |
| Palogic Value Management, L.P. | $153,000 | 100,000 | 1.58% | Shares |
| MILLENNIUM MANAGEMENT LLC | $147,927 | 96,684 | 1.53% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $143,965 | 94,095 | 1.49% | Shares |
| ABS Direct Equity Fund LLC | $111,975 | 73,186 | 1.16% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $83,380 | 54,497 | 0.86% | Shares |
| Rock Creek Group LLC | $60,072 | 39,263 | 0.62% | Shares |
| HighTower Advisors, LLC | $55,785 | 36,461 | 0.58% | Shares |
| GOLDMAN SACHS GROUP INC | $54,312 | 35,498 | 0.56% | Shares |
| SFMG, LLC | $50,490 | 33,000 | 0.52% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $43,118 | 28,182 | 0.45% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $35,927 | 23,482 | 0.37% | Shares |
| STATE STREET CORP | $33,431 | 21,850 | 0.35% | Shares |
| NORTHERN TRUST CORP | $32,467 | 21,220 | 0.34% | Shares |
| Mariner, LLC | $32,257 | 21,082 | 0.33% | Shares |
| Gleason Group, Inc. | $29,113 | 19,028 | 0.30% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $28,333 | 18,518 | 0.29% | Shares |
| JANE STREET GROUP, LLC | $25,709 | 16,803 | 0.27% | Shares |
| Qube Research & Technologies Ltd | $23,342 | 15,256 | 0.24% | Shares |
| Apollon Wealth Management, LLC | $21,440 | 14,013 | 0.22% | Shares |
| IEQ CAPITAL, LLC | $21,252 | 13,890 | 0.22% | Shares |
| ACT Advisors, LLC. | $19,702 | 12,877 | 0.20% | Shares |
| DEUTSCHE BANK AG\ | $18,720 | 12,235 | 0.19% | Shares |
| LPL Financial LLC | $18,306 | 11,965 | 0.19% | Shares |
| Sowell Financial Services LLC | $16,788 | 10,973 | 0.17% | Shares |
| Texas Capital Bank Wealth Management Services Inc | $16,656 | 10,886 | 0.17% | Shares |
| Green Ridge Wealth Planning LLC | $15,300 | 10,000 | 0.16% | Shares |
| JPMORGAN CHASE & CO | $12,049 | 7,626 | 0.12% | Shares |
| Global Retirement Partners, LLC | $9,563 | 6,250 | 0.10% | Shares |
| Vanguard Global Advisers, LLC | $7,806 | 5,102 | 0.08% | Shares |
| Tower Research Capital LLC (TRC) | $5,560 | 3,634 | 0.06% | Shares |
| RHUMBLINE ADVISERS | $5,538 | 3,620 | 0.06% | Shares |
| MERCER GLOBAL ADVISORS INC /ADV | $5,300 | 3,464 | 0.05% | Shares |
| CWM, LLC | $5,116 | 1,867 | 0.05% | Shares |
| FMR LLC | $4,983 | 3,257 | 0.05% | Shares |
| PNC Financial Services Group, Inc. | $3,845 | 2,513 | 0.04% | Shares |
| UBS Group AG | $2,249 | 1,470 | 0.02% | Shares |
| Arax Advisory Partners | $2,004 | 1,310 | 0.02% | Shares |
| OSAIC HOLDINGS, INC. | $1,530 | 1,000 | 0.02% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $1,515 | 990 | 0.02% | Shares |
| MORGAN STANLEY | $1,259 | 823 | 0.01% | Shares |
| Russell Investments Group, Ltd. | $1,030 | 673 | 0.01% | Shares |
| CITIGROUP INC | $604 | 395 | 0.01% | Shares |
| NISA INVESTMENT ADVISORS, LLC | $511 | 334 | 0.01% | Shares |
| Allworth Financial LP | $438 | 286 | 0.00% | Shares |
| Integrated Wealth Concepts LLC | $278 | 181 | 0.00% | Shares |
| BlackRock, Inc. | $260 | 170 | 0.00% | Shares |
| Essential Partners LLC | $256 | 167 | 0.00% | Shares |
| ROTHSCHILD INVESTMENT LLC | $190 | 124 | 0.00% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $113 | 74 | 0.00% | Shares |
| IFP Advisors, Inc | $112 | 73 | 0.00% | Shares |
| GAMMA Investing LLC | $99 | 65 | 0.00% | Shares |
| Farther Finance Advisors, LLC | $70 | 46 | 0.00% | Shares |
| Fortitude Family Office, LLC | $46 | 30 | 0.00% | Shares |
| True Wealth Design, LLC | $45 | 29 | 0.00% | Shares |
| Virtu Financial LLC | $22 | 14,611 | 0.00% | Shares |
| HRT FINANCIAL LP | $21 | 14,034 | 0.00% | Shares |
| EverSource Wealth Advisors, LLC | $18 | 12 | 0.00% | Shares |
| SJS Investment Consulting Inc. | $16 | 10 | 0.00% | Shares |
| WELLS FARGO & COMPANY/MN | $9 | 6 | 0.00% | Shares |
| BARCLAYS PLC | $2 | 1 | 0.00% | Shares |
| JPL Wealth Management, LLC | $2 | 1 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 31 | 0.00% | Shares |
Company insiders 6 insiders · 1 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Paul J Lytle | Chief Financial Officer | Aug. 14, 2024 A | — | 0 | 0 | $0 |
| Dan Zabrowski | Director | Aug. 12, 2024 A | — | 0 | 0 | $0 |
| Roger Sawhney | Director | Aug. 12, 2024 A | — | 0 | 0 | $0 |
| Jason A Keyes | Director | Aug. 12, 2024 A | — | 0 | 0 | $0 |
| Amy L Ronneberg | Director | Aug. 12, 2024 A | — | 0 | 0 | $0 |
| Daniel M Schmitt | — | Aug. 14, 2026 M | 301,716 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| BIOS FUND I, LP, BIOS FUND I QP, LP, BIOS FUND II, LP, BIOS FUND II QP, LP, BIOS FUND II NT, LP, BIOS FUND III, LP, BIOS FUND III QP, LP, BIOS FUND III NT, LP, BP DIRECTORS, LP, BIOS ACTUATE CO-INVEST I, LP, BIOS ACTUATE CO-INVEST II, LP, BIOS ACTUATE CO-INVEST III, LP, BIOS CLINICAL OPPORTUNITY FUND, LP, BIOS 2024 CO-INVEST, LP, BIOS EQUITY PARTNERS, LP, BIOS EQUITY PARTNERS II, LP, BIOS EQUITY PARTNERS III, LP, BIOS EQUITY COF, LP, CAVU MANAGEMENT, LP, BIOS CAPITAL MANAGEMENT, LP, CAVU ADVISORS, LLC, BIOS ADVISORS GP, LLC, LESLIE W. KREIS, AARON G.L. FLETCHER ×3 filings | June 30, 2025 | 49.50% | Amendment | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 7 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.00% | 38,230 SH | Aug. 8, 2026 | Daily |
| ITWO · ProShares Trust | 0.00% | 448 NS | May 31, 2026 | N-PORT |
| UWM · ProShares Trust | 0.00% | 350 NS | May 31, 2026 | N-PORT |
| URTY · ProShares Trust | 0.00% | 351 NS | May 31, 2026 | N-PORT |
| HDG · ProShares Trust | 0.00% | 9 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 106,048 SH | Aug. 8, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 287,385 SH | Aug. 8, 2026 | Daily |